Protect Pharmaceutical Corp (PRTT)
2.70
-0.01
(-0.37%)
USD |
OTCM |
May 17, 15:56
Protect Pharmaceutical Net Income (Quarterly): -0.0105M for June 30, 2016
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2016 | -0.0105M |
| March 31, 2016 | -0.0037M |
| December 31, 2015 | -0.0066M |
| September 30, 2015 | -0.6159M |
| June 30, 2015 | -0.0076M |
| March 31, 2015 | -0.0056M |
| December 31, 2014 | 0.4777M |
| September 30, 2014 | -0.0074M |
| June 30, 2014 | -0.0102M |
| March 31, 2014 | -0.002M |
| December 31, 2013 | -0.004M |
| September 30, 2013 | -0.0056M |
| June 30, 2013 | -0.0113M |
| March 31, 2013 | -0.0031M |
| December 31, 2012 | -0.0083M |
| Date | Value |
|---|---|
| September 30, 2012 | -0.1231M |
| June 30, 2012 | -0.1912M |
| March 31, 2012 | -0.2316M |
| December 31, 2011 | -0.5381M |
| September 30, 2011 | -0.1636M |
| June 30, 2011 | -0.5224M |
| March 31, 2011 | 0.4283M |
| December 31, 2010 | -0.4446M |
| September 30, 2010 | -0.0176M |
| June 30, 2010 | -5.312M |
| March 31, 2010 | -1.252M |
| December 31, 2009 | -0.0022M |
| September 30, 2009 | 0.00 |
| June 30, 2009 | 0.00 |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Tejon Ranch Co | -0.914M |
| Harte-Hanks Inc | -0.171M |
| Matthews International Corp | 9.027M |
| Seaboard Corp | 22.00M |
| 1847 Holdings LLC | -21.52M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 0.0105M |
| EPS Diluted (Quarterly) | -0.0094 |